ALS Center
  • Home
  • About ALS
    • About ALS
    • ALS Treatment Options
    • ALS Symptom Management
    • Frequently Asked Questions
    • Living with ALS
    • Everyday Life with ALS
  • Patient Care
    • The Clinic Experience
    • Multi Disciplinary Care
  • Research
    • Active Studies
    • Research Highlights
    • Research Teams
    • Other Resources
  • About Us
    • Our History
    • Our Team
    • News and Events
  • Donate
  • Contact
Select Page
CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS

CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS

by Michael Benatar | Dec 28, 2021 | Events, Press Releases

Dr. Michael Benatar is the Walter Bradley Chair in ALS Research, a Professor of Neurology at the University of Miami Miller School of Medicine and the Principal Investigator of the CReATe Consortium. In this interview, he will discuss the CReATe Consortium’s recent...
Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases

Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases

by Michael Benatar | Dec 14, 2021 | Events, Press Releases, Research Highlights

October 22, 2021 (University Of Miami press release) A groundbreaking clinical trial for unaffected individuals at risk for a genetic form of amyotrophic lateral sclerosis (ALS) could pave the way for early intervention strategies for other forms of ALS as well as a...
Learn how you can contribute to ALS research by donating CSF

Learn how you can contribute to ALS research by donating CSF

by Michael Benatar | Jul 1, 2021 | Events, Press Releases, Research Highlights

Many neurological disorders are poorly understood, in large part because researchers have few opportunities to directly study the brain and spinal cord. However, since cerebrospinal fluid (CSF), sometimes referred to simply as spinal fluid, baths the brain and spinal...
Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation

Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation

by Michael Benatar | Dec 11, 2020 | Events, Press Releases, Research Highlights

December 9, 2020 (University Of Miami press release) For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers and findings from...
ALS Center investigators host first international Pre-Symptomatic ALS Workshop

ALS Center investigators host first international Pre-Symptomatic ALS Workshop

by Michael Benatar | Oct 18, 2020 | Events, Press Releases, Research Highlights

The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in the fields of ALS, frontotemporal dementia (FTD), other...
« Older Entries

Recent Posts

  • CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS
  • Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases
  • Learn how you can contribute to ALS research by donating CSF
  • Miller School Studies Pave the Way for the First Pre-Symptomatic ALS Trial for Individuals with SOD1 Genetic Mutation
  • ALS Center investigators host first international Pre-Symptomatic ALS Workshop
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress